share_log

Jin Medical International | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

中进医疗 | 6-K:外国发行人报告

美股sec公告 ·  03/01 17:15
Moomoo AI 已提取核心信息
Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of March 2024, indicating a change of auditor. The company's previous auditor, DNTW Toronto LLP, resigned on February 26, 2024, effective immediately, from auditing the financial statements for the year ended September 30, 2023. There were no disagreements or reportable events between Jin Medical International and DNTW during the period from September 23, 2023, to February 28, 2024. Subsequently, on March 1, 2024, the company's Audit Committee appointed Audit Alliance LLP as the new independent registered public accounting firm. The company confirms that there were no consultations with DNTW regarding any reportable events during the two fiscal years ended December 31, 2023, and 2022, up to the date of the new auditor's appointment. The report was signed by Erqi Wang, Chief Executive Officer of Jin Medical International Ltd., on March 1, 2024.
Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of March 2024, indicating a change of auditor. The company's previous auditor, DNTW Toronto LLP, resigned on February 26, 2024, effective immediately, from auditing the financial statements for the year ended September 30, 2023. There were no disagreements or reportable events between Jin Medical International and DNTW during the period from September 23, 2023, to February 28, 2024. Subsequently, on March 1, 2024, the company's Audit Committee appointed Audit Alliance LLP as the new independent registered public accounting firm. The company confirms that there were no consultations with DNTW regarding any reportable events during the two fiscal years ended December 31, 2023, and 2022, up to the date of the new auditor's appointment. The report was signed by Erqi Wang, Chief Executive Officer of Jin Medical International Ltd., on March 1, 2024.
外国私人发行人Jin Medical International Ltd. 已向美国证券交易委员会(SEC)提交了2024年3月的报告,表示更换了审计师。该公司前任审计师DNTW Toronto LLP于2024年2月26日辞职,辞去截至2023年9月30日止年度的财务报表的审计职务,立即生效。在2023年9月23日至2024年2月28日期间,Jin Medical International和DNTW之间没有分歧或应报告的事件。随后,该公司的审计委员会于2024年3月1日任命审计联盟有限责任公司为新的独立注册会计师事务所。该公司证实,截至新审计师任命之日,在截至2023年12月31日和2022年的两个财政年度中,没有就任何应报告的事件与DNTW进行过磋商。该报告由金医疗国际有限公司首席执行官王尔奇于2024年3月1日签署。
外国私人发行人Jin Medical International Ltd. 已向美国证券交易委员会(SEC)提交了2024年3月的报告,表示更换了审计师。该公司前任审计师DNTW Toronto LLP于2024年2月26日辞职,辞去截至2023年9月30日止年度的财务报表的审计职务,立即生效。在2023年9月23日至2024年2月28日期间,Jin Medical International和DNTW之间没有分歧或应报告的事件。随后,该公司的审计委员会于2024年3月1日任命审计联盟有限责任公司为新的独立注册会计师事务所。该公司证实,截至新审计师任命之日,在截至2023年12月31日和2022年的两个财政年度中,没有就任何应报告的事件与DNTW进行过磋商。该报告由金医疗国际有限公司首席执行官王尔奇于2024年3月1日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息